AMG National Trust Bank Reduces Position in Henry Schein, Inc. (NASDAQ:HSIC)

AMG National Trust Bank trimmed its holdings in shares of Henry Schein, Inc. (NASDAQ:HSICGet Rating) by 1.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 13,001 shares of the company’s stock after selling 180 shares during the quarter. AMG National Trust Bank’s holdings in Henry Schein were worth $1,008,000 as of its most recent filing with the SEC.

Other large investors have also recently bought and sold shares of the company. Invesco Ltd. boosted its stake in Henry Schein by 0.6% in the third quarter. Invesco Ltd. now owns 4,614,393 shares of the company’s stock valued at $351,431,000 after acquiring an additional 29,498 shares during the period. American Century Companies Inc. raised its holdings in Henry Schein by 10.6% during the third quarter. American Century Companies Inc. now owns 3,156,804 shares of the company’s stock worth $240,422,000 after purchasing an additional 302,350 shares in the last quarter. Pendal Group Ltd increased its holdings in shares of Henry Schein by 73.3% in the third quarter. Pendal Group Ltd now owns 2,739,522 shares of the company’s stock valued at $208,642,000 after buying an additional 1,159,051 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of Henry Schein by 2.1% in the third quarter. Geode Capital Management LLC now owns 2,658,164 shares of the company’s stock valued at $201,937,000 after buying an additional 55,242 shares in the last quarter. Finally, Macquarie Group Ltd. increased its holdings in shares of Henry Schein by 57.2% in the third quarter. Macquarie Group Ltd. now owns 2,208,222 shares of the company’s stock valued at $168,161,000 after buying an additional 803,845 shares in the last quarter. Institutional investors and hedge funds own 93.73% of the company’s stock.

In other news, EVP Mark E. Mlotek sold 24,075 shares of the stock in a transaction that occurred on Thursday, February 24th. The shares were sold at an average price of $82.99, for a total transaction of $1,997,984.25. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Scott Philip Serota purchased 1,000 shares of the firm’s stock in a transaction dated Friday, March 4th. The shares were bought at an average cost of $85.87 per share, for a total transaction of $85,870.00. The disclosure for this purchase can be found here. 0.93% of the stock is currently owned by corporate insiders.

HSIC has been the topic of several research analyst reports. Robert W. Baird boosted their price target on shares of Henry Schein from $98.00 to $103.00 in a report on Wednesday, February 16th. Morgan Stanley upped their price objective on shares of Henry Schein from $67.00 to $72.00 and gave the stock an “underweight” rating in a report on Wednesday, February 16th. Piper Sandler cut their target price on shares of Henry Schein from $98.00 to $95.00 in a research report on Friday, January 28th. StockNews.com initiated coverage on shares of Henry Schein in a research report on Thursday, March 31st. They set a “buy” rating for the company. Finally, Barrington Research boosted their target price on shares of Henry Schein from $96.00 to $102.00 in a research report on Wednesday, February 16th. One analyst has rated the stock with a sell rating, one has given a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and an average price target of $92.33.

NASDAQ HSIC traded down $0.80 on Monday, reaching $90.56. The company’s stock had a trading volume of 2,411 shares, compared to its average volume of 1,008,225. The firm has a market cap of $12.50 billion, a PE ratio of 20.48, a price-to-earnings-growth ratio of 1.59 and a beta of 0.75. The business has a 50-day moving average price of $85.94 and a 200 day moving average price of $79.79. Henry Schein, Inc. has a 52 week low of $69.86 and a 52 week high of $92.68. The company has a current ratio of 1.67, a quick ratio of 0.86 and a debt-to-equity ratio of 0.20.

Henry Schein (NASDAQ:HSICGet Rating) last posted its earnings results on Tuesday, February 15th. The company reported $1.07 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.90 by $0.17. The business had revenue of $3.35 billion for the quarter, compared to analysts’ expectations of $3.14 billion. Henry Schein had a net margin of 5.09% and a return on equity of 15.84%. The firm’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.00 earnings per share. Analysts anticipate that Henry Schein, Inc. will post 4.86 earnings per share for the current fiscal year.

About Henry Schein (Get Rating)

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Read More

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSICGet Rating).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.